NEWS・COLUMN

We send the latest information from SMC Laboratories.

2023.06.12

PRODUCTS AND SERVICE

New Service: In Vitro Assay for Fibrosis Evaluation

We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation.  &nbsp…

READ MORE

2023.06.07

PRODUCTS AND SERVICE

Introducing our new pulmonary fibrosis model: Silica-induced pulmonary fibrosis model

Today, we are pleased to announce that we have expanded our preclinical model lineup by including the “S…

READ MORE

2023.05.24

PRODUCTS AND SERVICE

Introduction of Inflammatory Bowel Disease mouse model

Today, we give you a brief introduction to the dextran sulfate sodium (DSS) -induced colitis model, which is a…

READ MORE

2023.04.19

PRODUCTS AND SERVICE

Introduction of chronic kidney disease mice models

I am writing you today to share some information on our Chronic kidney disease (CKD) models.   CKD is a c…

READ MORE

2023.03.29

PRODUCTS AND SERVICE

Introduction of NASH model with high clinical correlation

Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Around t…

READ MORE

2023.02.22

PRODUCTS AND SERVICE

Introduction of bleomycin-induced SSc-ILD model

Today, we would like to introduce a more clinically correlative model in which skin and lung fibrosis develop …

READ MORE

2023.02.08

PRODUCTS AND SERVICE

Introduction of positive control drug for kidney fibrosis mouse model

Today, we would like to introduce an established positive control – an ALK5 inhibitor – for our Un…

READ MORE

2023.02.01

PRODUCTS AND SERVICE

Introduction of our experiences in histopathological analyses for IPF

Today, we present some new histopathological data from our bleomycin-induced pulmonary fibrosis model, which i…

READ MORE

2022.12.05

PRODUCTS AND SERVICE

Introduction of STAM™ model for pre-clinical studies for liver cancer

Today, we give you a brief introduction to our proprietary NASH-HCC model (STAM™ model). The STAM™…

READ MORE

2022.11.16

PRODUCTS AND SERVICE

Introducing our new skin disease model: Imiquimod (IMQ)-induced psoriasis model

We are pleased to announce that we have expanded our preclinical model lineup by including the “Imiquimo…

READ MORE

2022.10.26

PRODUCTS AND SERVICE

Introduction of our Primary sclerosing cholangitis (PSC) mice model

Today, I would like to give you a brief introduction into primary sclerosing cholangitis (PSC), as well as our…

READ MORE

2022.09.07

PRODUCTS AND SERVICE

Introducing our Idiopathic Pulmonary Fibrosis (IPF) mouse model

The outbreak of COVID-19 causes a lot of complications and long-term harm to the patient, especially severe pu…

READ MORE

Page 3 of 4First1234Last